Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Sotera Health Company SHC

Healthcare  —  Diagnostics & Research
18.34 (0.11) (0.60%) as of 25 Sep
Market cap
$5.3B
P/E
32.1×
Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Sotera Health Company (SHC) Business Profile

Updated before January 2025

Company Overview

Sotera Health Company (SHC) is a leading global provider of mission-critical health and sterilization solutions. Founded in 2015, the company is headquartered in Broadview Heights, Ohio, USA. SHC operates with a clear mission to safeguard global health by providing sterilization, lab testing, and advisory services to the healthcare and pharmaceutical industries. The company is led by a team of experienced executives, including its CEO, Michael B. Petras Jr., who has been instrumental in driving the company’s growth and innovation. SHC’s leadership team brings decades of expertise in healthcare, operations, and business strategy, ensuring the company remains at the forefront of its industry.

Core Business Segments

Sotera Health operates through three primary business segments, each offering a range of products and services designed to meet the needs of its diverse clientele:

1. Sterigenics

Sterigenics is a global leader in sterilization services, providing advanced solutions to ensure the safety and efficacy of medical devices, pharmaceuticals, and food products. Key offerings include:

  • Ethylene Oxide (EO) Sterilization: A widely used method for sterilizing medical devices and other sensitive products.
  • Gamma Irradiation: A sterilization technique that uses gamma rays to eliminate pathogens.
  • Electron Beam (E-Beam) Sterilization: A fast and efficient method for sterilizing products.

2. Nordion

Nordion specializes in the production and supply of Cobalt-60, a critical isotope used in gamma sterilization and radiation therapy. Key offerings include:

  • Cobalt-60 Supply: Ensuring a reliable source of this isotope for sterilization and medical applications.
  • Radiation Therapy Solutions: Supporting cancer treatment through advanced radiation technologies.

3. Nelson Labs

Nelson Labs provides comprehensive laboratory testing and advisory services to ensure the safety, quality, and compliance of medical devices, pharmaceuticals, and consumer products. Key offerings include:

  • Microbiology Testing: Ensuring products meet stringent safety standards.
  • Analytical Chemistry Testing: Providing insights into product composition and quality.
  • Regulatory Advisory Services: Helping clients navigate complex regulatory landscapes.

Business Model

Sotera Health’s business model is built on providing integrated solutions that combine products, services, and expertise to meet the critical needs of its clients. The company generates revenue through:

  • Service Contracts: Long-term agreements with healthcare and pharmaceutical companies for sterilization and testing services.
  • Product Sales: Supplying Cobalt-60 and other materials essential for sterilization and medical applications.
  • Consulting and Advisory Services: Offering regulatory and compliance expertise to clients worldwide.

By leveraging its global network of facilities and a highly skilled workforce, SHC ensures consistent quality and reliability across its operations. The company’s focus on innovation and customer-centric solutions has enabled it to build strong, long-term relationships with its clients.

Strategic Direction

Sotera Health is committed to driving growth and innovation while maintaining its focus on sustainability and global health. Key strategic priorities include:

  • Expanding Service Offerings: Investing in new technologies and capabilities to enhance its sterilization and testing services.
  • Sustainability Goals: Reducing its environmental footprint through energy-efficient operations and sustainable practices.
  • Geographic Expansion: Growing its presence in emerging markets to meet increasing demand for healthcare solutions.
  • Innovation: Developing new products and services to address evolving industry needs and regulatory requirements.

Competitive Landscape

Sotera Health operates in a competitive market, facing challenges from both established players and emerging companies. Key competitors include:

  • Steris Corporation: A major provider of sterilization and infection prevention solutions.
  • 3M Company: Known for its healthcare and safety products.
  • Cantel Medical: Specializes in infection prevention and control solutions.
  • Medline Industries: Offers a wide range of medical and surgical products.

Despite the competition, SHC’s comprehensive service offerings, global reach, and commitment to quality give it a strong competitive edge.

Risk Factors

Sotera Health faces several risks that could impact its operations and financial performance, including:

  • Market Dependence: Reliance on the healthcare and pharmaceutical industries for the majority of its revenue.
  • Regulatory Challenges: Navigating complex and evolving regulatory requirements in multiple jurisdictions.
  • Supply Chain Disruptions: Ensuring a consistent supply of raw materials and maintaining operational efficiency.
  • Economic Uncertainty: Potential impacts of global economic conditions on client demand and investment.

Recent Developments

Sotera Health has made significant strides in recent years, including:

  • Facility Expansions: Opening new sterilization and testing facilities to meet growing demand.
  • Technological Advancements: Investing in cutting-edge technologies to enhance service quality and efficiency.
  • Strategic Partnerships: Collaborating with industry leaders to drive innovation and expand its service offerings.
  • Global Developments: Adapting to challenges posed by the COVID-19 pandemic, including increased demand for sterilization services and supply chain disruptions.

Investment Considerations

Investors considering Sotera Health should weigh the following strengths and risks:

Strengths

  • Market Leadership: A leading position in the sterilization and testing industry.
  • Diverse Revenue Streams: Multiple business segments and service offerings.
  • Global Presence: A robust network of facilities and clients worldwide.
  • Commitment to Innovation: Continuous investment in new technologies and solutions.

Risks

  • Regulatory and Compliance Risks: Potential challenges in meeting evolving standards.
  • Economic Sensitivity: Dependence on healthcare and pharmaceutical industry trends.
  • Operational Risks: Ensuring consistent quality and efficiency across global operations.

Conclusion

Sotera Health Company is a vital player in the global healthcare ecosystem, providing essential sterilization and testing solutions that safeguard public health. With a strong market position, diverse service offerings, and a commitment to innovation, SHC is well-positioned for future growth. However, investors should carefully consider the risks associated with regulatory challenges and market dependence. Overall, SHC’s strategic direction and focus on sustainability make it a compelling choice for clients and investors alike.